Un Underestimated Symptom of Aortic Stenosis

For the first time, this long term observational study on a large cohort of contemporary patients with aortic stenosis (AS), has shown syncope is an underestimated threat, associated with worse prognosis after surgical aortic valve replacement (SAVR).

¿Qué usar para medir funcionalmente una lesión coronaria en el contexto de estenosis aórtica severa?It is interesting to note that other symptoms or early signs of AS that will normally indicate SAVR (dyspnea, angina or ventricular function deterioration) are associated with significantly better prognosis after SAVR. Patients presenting syncope usually display a specific pathophysiologic phenotype characterized by a smaller aortic valve area, smaller cardiac cavities, and lower stroke volumes.

 

The decision to replace the aortic valve is not always easy and requires thorough risk/Benefit ratio assessment.


Read also: Clinical Events after Deferral of LAD Treatment Guided by FFR or iFR.


Cardinal symptoms that indicate SAVR are angina, cardiac failure and syncope; however, it remains unclear whether these symptoms convey increased risk after SAVR or whether early detection, even when subtle, should be emphasized in the clinical practice.

 

A total 625 patients with isolated AS receiving elective SAVR were prospectively enrolled in this long-term study.

 

Patients presenting syncope had significantly smaller ventricular diameters (p=0.02), as well as smaller atrial diameters.


Read also: How long should we wait with asymptomatic aortic stenosis and preserved LVEF?


They also had smaller valve areas (p=0.048) and lower stroke index volume.

 

After adjusting for variables, syncope was associated with over 100% increased mortality risk  (HR 2.27, p=0.04) at one year, and again, over 100% increased mortality risk (HR 2.11, p<0.001) at 10 years. On the contrary, dyspnea, angina or preoperatory ventricular failure were not associated with worse evolution after SAVR.

 

Original title: Syncope. The Underestimated Threat in Severe Aortic Stenosis.

Reference: Georg Goliasch et al. J Am Coll Cardiol Img 2019. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...

J-Valve for Chronic AR: 30-Day Outcomes of Transfemoral Valve J-Valve in Chronic Aortic Regurgitation

Chronic aortic regurgitation (AR) poses a significant challenge as far as transcatheter alternatives go due to the absence of calcification and a suitable anchoring...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...